Month: September 2020

   Crédit Agricole S.A. confirme son engagement sur le marché Panda avec sa seconde émission obligataire benchmark de 1 milliard de CNY à 3 ans.Suite à l’émission obligataire Panda inaugurale de décembre 2019, Crédit Agricole S.A. a réalisé avec succès sa seconde émission de titres senior préférés de maturité 3 ans au taux fixe de 3,5% pour un montant de 1 milliard de CNY (équivalent à 123 millions d’euros). Crédit Agricole devient ainsi un émetteur régulier sur le marché obligataire Panda en plein essor, afin de financer ses activités en Chine et diversifier davantage son financement à long terme. Le produit de cette émission servira à financer sa filiale bancaire chinoise entièrement détenue, Crédit Agricole CIB (China) Limited, pour lui permettre de répondre aux besoins de sa clientèle internationale par le biais de financements et...

Publication on September 11, 2020, after market closingRegulated information – transparency notificationEVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR)Publication of a transparency notification

Publication le 11 septembre 2020, après la fermeture du marchéInformation réglementée – notification de transparenceEVS Broadcast Equipment SA: Euronext Bruxelles (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR)Publication relative à une notification de transparence

— Data for Investigational Gene Therapy Treatment NBIb-1817 (VY-AADC) Presented at the MDS Virtual Congress 2020 —NBIb-1817 Treatment Showed Sustained Improvement in Motor Function, Including Greater “On” Time without Troublesome Dyskinesia and Reduction in Unified Parkinson’s Disease Rating Scale (UPDRS) Part III Scores, and Reduction in the Amount of Medications Up to Three Years in Patients with Parkinson’s Disease14 of 15 Patients Treated with NBIb-1817 Continued to Experience an Improvement in Disease Staging after Three Years, as Assessed by the Modified Hoehn & Yahr Scale Re-Initiation of Enrollment in Registrational RESTORE-1 Clinical Trial of NBIb-1817 Planned for Later this YearSAN DIEGO and CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Voyager Therapeutics,...

WINNIPEG, Manitoba, Sept. 11, 2020 (GLOBE NEWSWIRE) — (TSX: NWC):  The North West Company Inc. (the “Company” or “North West”) today reported its unaudited financial results for the second quarter ended July 31, 2020. It also announced that the Board of Directors have declared a dividend of $0.36 per share, an increase of $0.03 per share or 9.1%, to shareholders of record on September 30, 2020, to be paid on October 15, 2020 and that, subject to TSX approval,  the Company intends to commence a normal course issuer bid.

Post hoc EXPAND analysis showed improvements in cognitive processing speed in patients with active and non-active SPMS treated with Mayzent1 Subgroup analyses of the EXPAND trial showed the value of early treatment initiation with Mayzent in patients with active SPMS as positive effects on disability, cognitive processing speed and relapse outcomes were sustained for up to five years2 Results from EXCHANGE interim analysis presented at ACTRIMS-ECTRIMS reinforced its safety and tolerability profile when patients switched from an oral or injectable disease-modifying therapy (DMT) to Mayzent3The digital press release with multimedia content can be accessed here: Basel, September 11, 2020 — Novartis announced today that Mayzent® (siponimod) analyses from the Phase IIIb EXCHANGE and EXPAND trials showed Mayzent to be a safe treatment option...

SANTA CLARA, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) — AMD (NASDAQ:AMD) today announced that the company’s senior unsecured credit rating was raised to investment grade Baa3 by Moody’s Investors Service.  “Our focus on roadmap execution and financial discipline during the last five years has created a solid foundation for long-term growth,” said Devinder Kumar, senior vice president, CFO and Treasurer, AMD. “We are pleased with this upgrade from Moody’s, which reflects our strong financial performance and outlook for continued growth and significant cash generation.”Moody’s upgraded AMD based on growing business momentum, share gains, strong financial performance, excellent liquidity and consistent execution. About AMDFor 50 years, AMD has driven innovation in high-performance computing, graphics and visualization technologies –...

New post hoc data from Phase III ASCLEPIOS trials showed newly diagnosed, treatment-naïve patients experienced reductions in annualized relapse rates, MRI lesion activity and reductions in time to disability worsening when treated with Kesimpta vs teriflunomide1Additional safety data in over 1,800 patients who continued Kesimpta treatment or switched therapy from previous studies reinforce the favorable safety profile of Kesimpta in patients with relapsing forms of multiple sclerosis (RMS)2 Baseline serum neurofilament light chain (NfL) levels in the ASCLEPIOS trials demonstrated a prognostic value for disease activity and worsening in all patients, including newly diagnosed, treatment-naïve patients3 Kesimpta is the first and only FDA-approved, self-administered, targeted B-cell therapy for adult with RMS4The digital press release with...

SCOTTSDALE, Ariz., Sept. 11, 2020 (GLOBE NEWSWIRE) — Electromedical Technologies, Inc. (OTCMKTS:EMED) (the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, is pleased to announce the hiring of Dr Rakhim Bulibekov  as in-house biophysicist to work directly with Nazarbayev University, Nur-Sultan, Kazakhstan, in the development of a comprehensive research program to study effects of electro-modulation on the insulin-dependent glucose uptake, pro-inflammatory or stress-dependent cytokine secretion, hypertension, tumor growth and viral infection in mammalian animal models. Regulation of the physiological responses by electro-modulation will provide a leverage for corrections of disease related physiological defects.The proposed Phase I studies in the animal models will serve to lay a foundation for...

It is the first time that Hong Kong connects directly with Mexico. The flight traveled more than 14 thousand kilometers with an Aeromexico Boeing 787 Dreamliner aircraft.  Mexico City, Sept. 11, 2020 (GLOBE NEWSWIRE) — Aeromexico registered a new record with the longest-range flight in the history of Mexican aviation. This is the first direct operation of the company between Hong Kong International Airport and Mexico City, with a distance of 14,170 kilometers, 55 more than its recent flight between Shenzhen, China, and the country’s capital.  One of the 19 airline’s Boeing 787 aircraft was used as a private charter operation to transport cargo even in the passenger cabin. This airplane is one of the most modern, efficient, and least polluting in the world. It produces 57% less noise pollution on takeoff and landing, and 20%...